This site is intended for healthcare professionals only
LoginRegister
Roche Susvimo maintains vision over five years with two refills per year in people with nAMDUSFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy
NPPA Sets New Retail Price for Cilnidipine, Telmisartan CombinationNPPA Sets New Retail Price for Cilnidipine, Telmisartan Combination
Shilpa Medicare Unit VI Bengaluru facilityShilpa Medicare Gets CDSCO Panel Nod for Novel NAFLD Drug, Advances to Marketing Approval Stage
Natco Pharma sees major leadership exit in RnD, demand & supply, qualityNatco Pharma Q3 Profit Falls 38% to Rs132 Cr Amid Formulation Export Slump
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataGlenmark Rolls Out Generic Xalatan in US, Targets USD 113M Market
Nestle CEO Backs Packaged Food as Essential Amid U.S. Health DebateNestle CEO Backs Packaged Food as Essential Amid U.S. Health Debate
Relief for Drugmakers: Health Ministry Extends Schedule M Deadline, Sets Compliance TermsRelief for Drugmakers: Health Ministry Extends Schedule M Deadline, Sets Compliance Terms
Novartis concludes acquisition of Regulus TherapeuticsPE Giants Vie for Gland Pharma in USD 3 Billion Blockbuster Buyout
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterationsJohnson & Johnson MedTech launches CEREGLIDE 92 Catheter System for Acute ischemic stroke
USFDA approves Pfizer Adcetris combination regimen for Relapsed/Refractory Diffuse Large B-Cell LymphomaUSFDA approves Pfizer Adcetris combination regimen for Relapsed/Refractory Diffuse Large B-Cell...
Dr Pavan Ganapati Bhat resigns as Director & Executive Vice President (Technical Operations) of Natco PharmaDr Pavan Ganapati Bhat resigns as Director & Executive Vice President (Technical Operations) of...
USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoeaZydus Lifesciences, Synthon ink pact for new oncology product
X